Actively Recruiting
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Led by Kestra Medical Technologies, Inc. · Updated on 2025-09-02
5179
Participants Needed
1
Research Sites
201 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
CONDITIONS
Official Title
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient prescribed the ASSURE wearable cardioverter defibrillator
- Provided written informed consent to participate in the ASSURE Patient Registry
You will not qualify if you...
- Patients who do not meet the Inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Washington Medical Center
Seattle, Washington, United States, 98033
Actively Recruiting
Research Team
K
Kristin Eis, BSChE, MBA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here